LDL-receptor protein is degraded by proprotein convertase subtilisin or kexin type 9 (PCSK9): LoF mutations in PCSK9 protect against CVD, whereas GoF mutations are associated with hypercholesterolemia and accelerated CVD57–59, demonstrating the critical role of this pathway. This evidence concerns the gene LDLR and familial hypercholesterolemia.